| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | type I interferon receptor binding | 5.70e-16 | 17 | 74 | 8 | GO:0005132 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | RIPK1 CD2AP IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 2.92e-08 | 324 | 74 | 11 | GO:0005126 |
| GeneOntologyMolecularFunction | cytokine activity | 3.56e-07 | 250 | 74 | 9 | GO:0005125 | |
| GeneOntologyMolecularFunction | receptor ligand activity | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 3.26e-05 | 547 | 74 | 10 | GO:0048018 |
| GeneOntologyMolecularFunction | signaling receptor activator activity | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 3.63e-05 | 554 | 74 | 10 | GO:0030546 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 8.81e-05 | 616 | 74 | 10 | GO:0030545 |
| GeneOntologyMolecularFunction | myosin light chain binding | 3.74e-04 | 8 | 74 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 7.29e-04 | 11 | 74 | 2 | GO:0043139 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 3.64e-15 | 21 | 74 | 8 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 1.31e-14 | 24 | 74 | 8 | GO:0033139 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 5.45e-14 | 28 | 74 | 8 | GO:0042501 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.99e-12 | 42 | 74 | 8 | GO:0002323 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 1.98e-11 | 55 | 74 | 8 | GO:0043330 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 6.15e-11 | 63 | 74 | 8 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 6.15e-11 | 63 | 74 | 8 | GO:0050691 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 7.18e-10 | 85 | 74 | 8 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 7.89e-10 | 86 | 74 | 8 | GO:0071357 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.14e-09 | 90 | 74 | 8 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.14e-09 | 90 | 74 | 8 | GO:0050688 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.36e-09 | 92 | 74 | 8 | GO:0034340 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 2.88e-09 | 101 | 74 | 8 | GO:0033138 | |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 6.57e-09 | 112 | 74 | 8 | GO:0140888 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.47e-08 | 124 | 74 | 8 | GO:0030101 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.47e-08 | 124 | 74 | 8 | GO:0042100 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.57e-08 | 125 | 74 | 8 | GO:0046425 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 3.21e-08 | 137 | 74 | 8 | GO:0033135 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 4.49e-08 | 143 | 74 | 8 | GO:1904892 | |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 5.87e-08 | 148 | 74 | 8 | GO:0002286 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 5.49e-07 | 198 | 74 | 8 | GO:0007259 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 6.15e-07 | 201 | 74 | 8 | GO:0030183 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | RIPK1 GOLGA8H GOLGA8K DLG3 IL1B PDGFC CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.57e-07 | 937 | 74 | 15 | GO:0031401 |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 1.06e-06 | 216 | 74 | 8 | GO:0097696 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 1.51e-06 | 307 | 74 | 9 | GO:0018105 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | IL1B CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.53e-06 | 398 | 74 | 10 | GO:0046651 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | KAT2B RIPK1 ERO1A DLG3 PDGFC CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.59e-06 | 976 | 74 | 15 | GO:0018193 |
| GeneOntologyBiologicalProcess | defense response to bacterium | UNC13B STAB2 IL1B IFNA2 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.79e-06 | 405 | 74 | 10 | GO:0042742 |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | IL1B CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.83e-06 | 406 | 74 | 10 | GO:0032943 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 2.07e-06 | 319 | 74 | 9 | GO:0018209 | |
| GeneOntologyBiologicalProcess | humoral immune response | 2.18e-06 | 321 | 74 | 9 | GO:0006959 | |
| GeneOntologyBiologicalProcess | response to virus | CD2AP IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 2.75e-06 | 425 | 74 | 10 | GO:0009615 |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 3.24e-06 | 251 | 74 | 8 | GO:0002285 | |
| GeneOntologyBiologicalProcess | defense response to virus | 3.65e-06 | 342 | 74 | 9 | GO:0051607 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | IL1B CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 4.13e-06 | 445 | 74 | 10 | GO:0070661 |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | RIPK1 DLG3 IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.53e-06 | 724 | 74 | 12 | GO:0001934 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | KAT2B RIPK1 DLG3 IL1B PDGFC CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.78e-06 | 1133 | 74 | 15 | GO:0001932 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | KAT2B RIPK1 DLG3 IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.32e-05 | 879 | 74 | 13 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | KAT2B RIPK1 DLG3 IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.32e-05 | 879 | 74 | 13 | GO:0010562 |
| GeneOntologyBiologicalProcess | regulation of protein modification process | KAT2B RIPK1 GOLGA8H GOLGA8K DLG3 IL1B PDGFC CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.57e-05 | 1488 | 74 | 17 | GO:0031399 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RIPK1 DLG3 IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 2.00e-05 | 780 | 74 | 12 | GO:0042327 |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | KAT2B RIPK1 DLG3 IL1B PDGFC CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 2.48e-05 | 1226 | 74 | 15 | GO:0042325 |
| GeneOntologyBiologicalProcess | B cell activation | 3.00e-05 | 341 | 74 | 8 | GO:0042113 | |
| GeneOntologyBiologicalProcess | T cell activation | IL1B CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 3.85e-05 | 701 | 74 | 11 | GO:0042110 |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 3.90e-05 | 577 | 74 | 10 | GO:0019221 |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | 4.49e-05 | 361 | 74 | 8 | GO:0002366 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | 4.85e-05 | 365 | 74 | 8 | GO:0002263 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.26e-05 | 640 | 74 | 10 | GO:1903131 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 1.26e-04 | 537 | 74 | 9 | GO:0030098 | |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | KAT2B RIPK1 DLG3 IL1B PDGFC CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.33e-04 | 1421 | 74 | 15 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | KAT2B RIPK1 DLG3 IL1B PDGFC CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.35e-04 | 1423 | 74 | 15 | GO:0051174 |
| GeneOntologyBiologicalProcess | negative regulation of cell population proliferation | KAT2B DLG3 IL1B CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.49e-04 | 961 | 74 | 12 | GO:0008285 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | KAT2B CYFIP1 HCN1 CD2AP IL1B MEAK7 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.50e-04 | 1272 | 74 | 14 | GO:1901698 |
| GeneOntologyBiologicalProcess | lymphocyte activation | CD2AP IL1B CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.72e-04 | 976 | 74 | 12 | GO:0046649 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | RIPK1 GOLGA8H GOLGA8K DLG3 IL1B PDGFC CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.77e-04 | 1458 | 74 | 15 | GO:0051247 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | WDR19 NCOA3 SYCP2 SPATA6L MEIOC SYNE1 CD2AP TAF7L PRND APOB IL1B SPAG17 DEDD | 4.09e-04 | 1235 | 74 | 13 | GO:0003006 |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 4.61e-04 | 100 | 74 | 4 | GO:1903510 | |
| GeneOntologyBiologicalProcess | regulation of response to biotic stimulus | 4.77e-04 | 643 | 74 | 9 | GO:0002831 | |
| GeneOntologyBiologicalProcess | protein-containing complex localization | 4.88e-04 | 278 | 74 | 6 | GO:0031503 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 4.97e-04 | 789 | 74 | 10 | GO:0002521 |
| GeneOntologyBiologicalProcess | DNA repair | 5.05e-04 | 648 | 74 | 9 | GO:0006281 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 6.42e-04 | 47 | 74 | 3 | GO:0045494 | |
| GeneOntologyBiologicalProcess | heparin biosynthetic process | 6.84e-04 | 11 | 74 | 2 | GO:0030210 | |
| GeneOntologyBiologicalProcess | organelle assembly | WDR19 KAT2B NRXN3 PRRC2C SYNE1 GOLGA8H GOLGA8K CEP152 RP1 NUDCD3 SPAG17 NOP2 | 6.90e-04 | 1138 | 74 | 12 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of cell division | 7.81e-04 | 201 | 74 | 5 | GO:0051302 | |
| GeneOntologyBiologicalProcess | adaptive immune response | IL1B DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 7.92e-04 | 838 | 74 | 10 | GO:0002250 |
| GeneOntologyBiologicalProcess | cell division | 8.49e-04 | 697 | 74 | 9 | GO:0051301 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan metabolic process | 9.45e-04 | 121 | 74 | 4 | GO:0030203 | |
| GeneOntologyBiologicalProcess | immune effector process | IL1B DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.56e-04 | 859 | 74 | 10 | GO:0002252 |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 9.74e-04 | 122 | 74 | 4 | GO:0045132 | |
| GeneOntologyBiologicalProcess | leukocyte activation | CD2AP IL1B CBLB DUSP22 IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.90e-04 | 1186 | 74 | 12 | GO:0045321 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.03e-03 | 321 | 74 | 6 | GO:0099003 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | NCOA3 HCN1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.22e-03 | 1048 | 74 | 11 | GO:0014070 |
| GeneOntologyBiologicalProcess | aminoglycan metabolic process | 1.30e-03 | 132 | 74 | 4 | GO:0006022 | |
| GeneOntologyBiologicalProcess | response to bacterium | UNC13B STAB2 IL1B IFNA2 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.55e-03 | 916 | 74 | 10 | GO:0009617 |
| GeneOntologyBiologicalProcess | retina homeostasis | 1.58e-03 | 64 | 74 | 3 | GO:0001895 | |
| GeneOntologyBiologicalProcess | male gamete generation | 1.58e-03 | 762 | 74 | 9 | GO:0048232 | |
| GeneOntologyBiologicalProcess | heparin metabolic process | 1.67e-03 | 17 | 74 | 2 | GO:0030202 | |
| GeneOntologyCellularComponent | somatodendritic compartment | BPTF CYFIP1 MYOT TRIM9 SYNE1 ERO1A HCN1 CD2AP GOLGA8H TMEM266 GOLGA8K DLG3 APOB WDR47 | 1.04e-04 | 1228 | 75 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | Mon1-Ccz1 complex | 1.26e-04 | 5 | 75 | 2 | GO:0035658 | |
| GeneOntologyCellularComponent | distal axon | 1.64e-04 | 435 | 75 | 8 | GO:0150034 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 2.24e-04 | 33 | 75 | 3 | GO:0000137 | |
| GeneOntologyCellularComponent | clathrin complex | 4.50e-04 | 9 | 75 | 2 | GO:0071439 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 6.83e-04 | 48 | 75 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | axon terminus | 9.52e-04 | 210 | 75 | 5 | GO:0043679 | |
| GeneOntologyCellularComponent | dendrite | 9.53e-04 | 858 | 75 | 10 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 9.70e-04 | 860 | 75 | 10 | GO:0097447 | |
| GeneOntologyCellularComponent | DNA replication factor A complex | 1.12e-03 | 14 | 75 | 2 | GO:0005662 | |
| GeneOntologyCellularComponent | axon | 1.27e-03 | 891 | 75 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.51e-03 | 233 | 75 | 5 | GO:0044306 | |
| GeneOntologyCellularComponent | cell body | BPTF CYFIP1 MYOT HCN1 GOLGA8H TMEM266 GOLGA8K DLG3 APOB WDR47 | 1.73e-03 | 929 | 75 | 10 | GO:0044297 |
| Domain | Interferon_alpha/beta/delta | 8.67e-16 | 17 | 73 | 8 | IPR000471 | |
| Domain | Interferon | 8.67e-16 | 17 | 73 | 8 | PF00143 | |
| Domain | IFabd | 8.67e-16 | 17 | 73 | 8 | SM00076 | |
| Domain | INTERFERON_A_B_D | 8.67e-16 | 17 | 73 | 8 | PS00252 | |
| Domain | - | 1.73e-11 | 50 | 73 | 8 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 2.04e-11 | 51 | 73 | 8 | IPR012351 | |
| Domain | 4_helix_cytokine-like_core | 4.50e-10 | 74 | 73 | 8 | IPR009079 | |
| Domain | DUF1712 | 1.51e-05 | 2 | 73 | 2 | PF08217 | |
| Domain | DUF1712_fun | 1.51e-05 | 2 | 73 | 2 | IPR013176 | |
| Domain | Bromodomain_CS | 4.61e-03 | 26 | 73 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 9.19e-03 | 37 | 73 | 2 | PS00633 | |
| Domain | Bromodomain | 9.67e-03 | 38 | 73 | 2 | PF00439 | |
| Domain | Ion_trans_dom | 1.01e-02 | 114 | 73 | 3 | IPR005821 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 1.17e-15 | 17 | 58 | 8 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 2.11e-15 | 18 | 58 | 8 | M47539 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 3.32e-15 | 31 | 58 | 9 | M47964 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 3.62e-15 | 19 | 58 | 8 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 6.02e-15 | 20 | 58 | 8 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 9.70e-15 | 21 | 58 | 8 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 1.52e-14 | 22 | 58 | 8 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 1.52e-14 | 22 | 58 | 8 | M47616 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.56e-14 | 55 | 58 | 10 | M11844 |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 2.32e-14 | 23 | 58 | 8 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 2.32e-14 | 23 | 58 | 8 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 3.47e-14 | 24 | 58 | 8 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 3.47e-14 | 24 | 58 | 8 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.47e-14 | 24 | 58 | 8 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 7.33e-14 | 26 | 58 | 8 | M982 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 2.71e-13 | 30 | 58 | 8 | M936 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 3.13e-13 | 73 | 58 | 10 | M39837 |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 3.64e-13 | 31 | 58 | 8 | M39897 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 6.65e-13 | 19 | 58 | 7 | MM1571 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 8.30e-13 | 34 | 58 | 8 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 1.07e-12 | 35 | 58 | 8 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 1.07e-12 | 35 | 58 | 8 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.75e-12 | 37 | 58 | 8 | M39785 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.77e-12 | 39 | 58 | 8 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 4.27e-12 | 41 | 58 | 8 | MM1493 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 9.81e-12 | 102 | 58 | 10 | M3261 |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 1.08e-11 | 71 | 58 | 9 | M15913 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | RIPK1 IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.08e-11 | 103 | 58 | 10 | M39434 |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 1.52e-11 | 28 | 58 | 7 | MM1378 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 3.25e-11 | 52 | 58 | 8 | M13103 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 4.11e-11 | 82 | 58 | 9 | M1002 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 5.40e-11 | 33 | 58 | 7 | MM1379 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | IL1B CBLB IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.76e-10 | 136 | 58 | 10 | M42547 |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 2.09e-10 | 65 | 58 | 8 | M272 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 9.33e-10 | 78 | 58 | 8 | M973 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 2.16e-09 | 127 | 58 | 9 | M42533 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.48e-09 | 88 | 58 | 8 | M16004 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 5.88e-09 | 98 | 58 | 8 | M48247 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 1.25e-08 | 155 | 58 | 9 | M17411 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 2.93e-08 | 120 | 58 | 8 | M48233 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.29e-08 | 126 | 58 | 8 | M45009 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 6.22e-08 | 87 | 58 | 7 | MM15915 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 8.25e-08 | 137 | 58 | 8 | M5669 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 8.73e-08 | 138 | 58 | 8 | MM15635 | |
| Pathway | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.06e-07 | 264 | 58 | 10 | M9809 |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.75e-07 | 151 | 58 | 8 | M39801 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 4.35e-07 | 170 | 58 | 8 | M941 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL6A2 PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 7.43e-07 | 326 | 58 | 10 | MM15917 |
| Pathway | WP_PI3KAKT_SIGNALING | COL6A2 PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.06e-06 | 339 | 58 | 10 | M39736 |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 1.73e-06 | 204 | 58 | 8 | M45011 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.48e-05 | 273 | 58 | 8 | M983 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | 2.85e-05 | 299 | 58 | 8 | M41727 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 9.92e-05 | 59 | 58 | 4 | M48104 | |
| Pathway | REACTOME_SARS_COV_INFECTIONS | 1.19e-04 | 471 | 58 | 9 | M39009 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 1.21e-04 | 472 | 58 | 9 | MM14539 | |
| Pathway | WP_CANCER_PATHWAYS | 2.08e-04 | 507 | 58 | 9 | M48302 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 2.47e-04 | 6 | 58 | 2 | MM1447 | |
| Pathway | REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER | 3.72e-04 | 83 | 58 | 4 | MM15305 | |
| Pathway | REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER | 3.90e-04 | 84 | 58 | 4 | M27594 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS | 8.93e-04 | 11 | 58 | 2 | M47921 | |
| Pathway | REACTOME_NUCLEOTIDE_EXCISION_REPAIR | 1.01e-03 | 108 | 58 | 4 | M7927 | |
| Pathway | REACTOME_NUCLEOTIDE_EXCISION_REPAIR | 1.01e-03 | 108 | 58 | 4 | MM15304 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | CYFIP1 RIPK1 TAF7L IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.28e-03 | 1081 | 58 | 12 | M27548 |
| Pathway | REACTOME_HEMOSTASIS | 1.69e-03 | 679 | 58 | 9 | M8395 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | CYFIP1 RIPK1 APOB IL1B IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.84e-03 | 1128 | 58 | 12 | M1036 |
| Pathway | BIOCARTA_PDZS_PATHWAY | 2.44e-03 | 18 | 58 | 2 | M22001 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | RIPK1 TAF7L IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 3.08e-03 | 888 | 58 | 10 | M48034 |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.65e-03 | 22 | 58 | 2 | MM1370 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 3.98e-03 | 23 | 58 | 2 | MM14620 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 3.98e-03 | 23 | 58 | 2 | M39883 | |
| Pathway | WP_POSTCOVID_NEUROINFLAMMATION | 3.98e-03 | 23 | 58 | 2 | M48313 | |
| Pubmed | 2.93e-20 | 18 | 75 | 9 | 1905933 | ||
| Pubmed | 5.57e-20 | 19 | 75 | 9 | 7511078 | ||
| Pubmed | 5.57e-20 | 19 | 75 | 9 | 7815507 | ||
| Pubmed | 1.01e-19 | 20 | 75 | 9 | 8764000 | ||
| Pubmed | 1.56e-19 | 12 | 75 | 8 | 16565497 | ||
| Pubmed | 1.56e-19 | 12 | 75 | 8 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.56e-19 | 12 | 75 | 8 | 8760352 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.56e-19 | 12 | 75 | 8 | 17512142 | |
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.56e-19 | 12 | 75 | 8 | 1886773 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.56e-19 | 12 | 75 | 8 | 7530016 | |
| Pubmed | 1.56e-19 | 12 | 75 | 8 | 9794206 | ||
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.56e-19 | 12 | 75 | 8 | 7684767 | |
| Pubmed | 1.56e-19 | 12 | 75 | 8 | 17451966 | ||
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.56e-19 | 12 | 75 | 8 | 16611902 | |
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.56e-19 | 12 | 75 | 8 | 22912583 | |
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.56e-19 | 12 | 75 | 8 | 3758677 | |
| Pubmed | 1.56e-19 | 12 | 75 | 8 | 8245849 | ||
| Pubmed | 1.76e-19 | 21 | 75 | 9 | 9108403 | ||
| Pubmed | 2.98e-19 | 22 | 75 | 9 | 16160188 | ||
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 4.06e-19 | 13 | 75 | 8 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 4.06e-19 | 13 | 75 | 8 | 2014240 | |
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 18005734 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 12050368 | ||
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 4.06e-19 | 13 | 75 | 8 | 2987810 | |
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 4.06e-19 | 13 | 75 | 8 | 6094686 | |
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 19130550 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 1655578 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 2471809 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 22739040 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 8438572 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 9343822 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 9181467 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 4.06e-19 | 13 | 75 | 8 | 23255800 | |
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 7523540 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 4.06e-19 | 13 | 75 | 8 | 18726328 | |
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 19706714 | ||
| Pubmed | 4.06e-19 | 13 | 75 | 8 | 18572754 | ||
| Pubmed | 4.89e-19 | 23 | 75 | 9 | 9225992 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 14983024 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 9.45e-19 | 14 | 75 | 8 | 7526537 | |
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 19559726 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 25972534 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 15240719 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 7583919 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 16418394 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 18272764 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 2987811 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 11884139 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 19004943 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 21172865 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 2552026 | ||
| Pubmed | Characterization of the murine alpha interferon gene family. | 9.45e-19 | 14 | 75 | 8 | 15254193 | |
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 9.45e-19 | 14 | 75 | 8 | 7532202 | |
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 16278001 | ||
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 9.45e-19 | 14 | 75 | 8 | 18200009 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 9.45e-19 | 14 | 75 | 8 | 17517919 | |
| Pubmed | Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. | 9.45e-19 | 14 | 75 | 8 | 1381203 | |
| Pubmed | 9.45e-19 | 14 | 75 | 8 | 8345204 | ||
| Pubmed | Modulation of HIV-1 transcription by cytokines and chemokines. | 1.22e-18 | 25 | 75 | 9 | 16375755 | |
| Pubmed | The RIPK1 death domain restrains ZBP1- and TRIF-mediated cell death and inflammation. | 1.86e-18 | 26 | 75 | 9 | 38744293 | |
| Pubmed | 1.86e-18 | 26 | 75 | 9 | 9658081 | ||
| Pubmed | Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? | 2.02e-18 | 15 | 75 | 8 | 17180012 | |
| Pubmed | Role of the Akt pathway in mRNA translation of interferon-stimulated genes. | 2.02e-18 | 15 | 75 | 8 | 18339807 | |
| Pubmed | 2.02e-18 | 15 | 75 | 8 | 8786318 | ||
| Pubmed | 2.02e-18 | 15 | 75 | 8 | 15684736 | ||
| Pubmed | Interferon induction by HIV-1-infected cells: a possible role of sulfatides or related glycolipids. | 2.02e-18 | 15 | 75 | 8 | 8661419 | |
| Pubmed | 2.02e-18 | 15 | 75 | 8 | 9520456 | ||
| Pubmed | Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5. | 2.79e-18 | 27 | 75 | 9 | 33165593 | |
| Pubmed | Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. | 4.04e-18 | 16 | 75 | 8 | 22315404 | |
| Pubmed | Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. | 4.04e-18 | 16 | 75 | 8 | 18414664 | |
| Pubmed | Coordinate induction of interferon alpha and gamma by recombinant HIV-1 glycoprotein 120. | 4.04e-18 | 16 | 75 | 8 | 7904170 | |
| Pubmed | 4.10e-18 | 28 | 75 | 9 | 15481145 | ||
| Pubmed | Characterization of the type I interferon locus and identification of novel genes. | 7.61e-18 | 17 | 75 | 8 | 15233997 | |
| Pubmed | 7.61e-18 | 17 | 75 | 8 | 22814248 | ||
| Pubmed | 2.36e-17 | 19 | 75 | 8 | 1385305 | ||
| Pubmed | 2.36e-17 | 19 | 75 | 8 | 17360657 | ||
| Pubmed | A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. | 2.36e-17 | 19 | 75 | 8 | 24784232 | |
| Pubmed | Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. | 2.36e-17 | 19 | 75 | 8 | 1708818 | |
| Pubmed | TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. | 3.92e-17 | 20 | 75 | 8 | 11694501 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 5.33e-17 | 11 | 75 | 7 | 8389790 | |
| Pubmed | 5.33e-17 | 11 | 75 | 7 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 5.33e-17 | 11 | 75 | 7 | 6444699 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 5.33e-17 | 11 | 75 | 7 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 5.33e-17 | 11 | 75 | 7 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 5.33e-17 | 11 | 75 | 7 | 15795237 | |
| Pubmed | 5.33e-17 | 11 | 75 | 7 | 9794439 | ||
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 5.33e-17 | 11 | 75 | 7 | 10448195 | |
| Pubmed | 5.33e-17 | 11 | 75 | 7 | 25310498 | ||
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 5.33e-17 | 11 | 75 | 7 | 19120292 | |
| Pubmed | 9.93e-17 | 22 | 75 | 8 | 7913356 | ||
| Pubmed | 9.93e-17 | 22 | 75 | 8 | 23100517 | ||
| Pubmed | 9.93e-17 | 22 | 75 | 8 | 20574843 | ||
| Pubmed | 1.28e-16 | 12 | 75 | 7 | 22685550 | ||
| Pubmed | 1.28e-16 | 12 | 75 | 7 | 3017340 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.28e-16 | 12 | 75 | 7 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.28e-16 | 12 | 75 | 7 | 33123150 | |
| Pubmed | 1.28e-16 | 12 | 75 | 7 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 1.28e-16 | 12 | 75 | 7 | 8304945 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.28e-16 | 12 | 75 | 7 | 27988795 | |
| Interaction | IFNA5 interactions | 1.31e-10 | 22 | 73 | 6 | int:IFNA5 | |
| Interaction | IFNA6 interactions | 1.10e-08 | 8 | 73 | 4 | int:IFNA6 | |
| Interaction | IFNA14 interactions | 2.79e-07 | 16 | 73 | 4 | int:IFNA14 | |
| Interaction | IFNA1 interactions | 2.79e-07 | 16 | 73 | 4 | int:IFNA1 | |
| Interaction | IFNA13 interactions | 7.37e-06 | 11 | 73 | 3 | int:IFNA13 | |
| Interaction | UBR3 interactions | 2.98e-05 | 99 | 73 | 5 | int:UBR3 | |
| Cytoband | 9p22 | 3.65e-17 | 25 | 75 | 8 | 9p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 3.27e-11 | 124 | 75 | 8 | chr9p21 | |
| Cytoband | 15q13.2 | 5.42e-04 | 21 | 75 | 2 | 15q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 6.04e-04 | 100 | 75 | 3 | chr15q13 | |
| Cytoband | 14q22.1 | 1.11e-03 | 30 | 75 | 2 | 14q22.1 | |
| Cytoband | 4q26 | 2.38e-03 | 44 | 75 | 2 | 4q26 | |
| Cytoband | 7p22.1 | 2.71e-03 | 47 | 75 | 2 | 7p22.1 | |
| Cytoband | 1q23.3 | 2.95e-03 | 49 | 75 | 2 | 1q23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q26 | 3.70e-03 | 55 | 75 | 2 | chr4q26 | |
| GeneFamily | Interferons | 7.68e-15 | 32 | 45 | 8 | 598 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 8.04e-04 | 17 | 45 | 2 | 486 | |
| GeneFamily | Ubiquitin specific peptidases | 8.57e-03 | 56 | 45 | 2 | 366 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 1.75e-12 | 29 | 75 | 7 | MM586 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.71e-12 | 85 | 75 | 9 | MM684 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 1.68e-11 | 39 | 75 | 7 | M41095 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 7.52e-11 | 80 | 75 | 8 | MM1229 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 3.17e-09 | 80 | 75 | 7 | MM646 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.00e-09 | 131 | 75 | 8 | MM1127 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 5.74e-09 | 87 | 75 | 7 | MM652 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 9.11e-09 | 210 | 75 | 9 | MM751 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.29e-08 | 27 | 75 | 5 | M40935 | |
| Coexpression | NABA_SECRETED_FACTORS | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 4.39e-08 | 338 | 75 | 10 | MM17064 |
| Coexpression | NABA_SECRETED_FACTORS | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 5.04e-08 | 343 | 75 | 10 | M5883 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.09e-06 | 32 | 75 | 4 | M40934 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.69e-06 | 34 | 75 | 4 | M41094 | |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN | 2.11e-05 | 19 | 75 | 3 | M40933 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | 4.32e-05 | 584 | 75 | 9 | MM1080 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 4.69e-05 | 738 | 75 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 5.42e-05 | 751 | 75 | 10 | M5885 |
| Coexpression | LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP | 7.79e-05 | 29 | 75 | 3 | M41150 | |
| Coexpression | NABA_MATRISOME | COL6A2 IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.33e-04 | 1008 | 75 | 11 | MM17056 |
| Coexpression | KRAS.600_UP.V1_DN | 1.50e-04 | 279 | 75 | 6 | M2880 | |
| Coexpression | NABA_MATRISOME | COL6A2 IL1B PDGFC IFNA2 IFNA5 IFNA6 IFNA10 IFNA14 IFNA16 IFNA17 IFNA21 | 1.55e-04 | 1026 | 75 | 11 | M5889 |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN | 2.57e-04 | 197 | 75 | 5 | M4294 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 2.57e-04 | 197 | 75 | 5 | M3193 | |
| Coexpression | GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN | 2.75e-04 | 200 | 75 | 5 | M4398 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#4_top-relative-expression-ranked_100 | 3.01e-05 | 20 | 65 | 3 | gudmap_developingGonad_e18.5_ovary_100_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_100 | 6.00e-05 | 25 | 65 | 3 | gudmap_developingGonad_e16.5_ovary_100_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 7.71e-05 | 143 | 65 | 5 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_200 | 1.53e-04 | 34 | 65 | 3 | gudmap_developingGonad_e18.5_ovary_200_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_100 | 1.53e-04 | 34 | 65 | 3 | gudmap_developingGonad_e14.5_ ovary_100_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 1.72e-04 | 385 | 65 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_200 | 1.82e-04 | 36 | 65 | 3 | gudmap_developingGonad_e16.5_ovary_200_k2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.47e-07 | 171 | 75 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.32e-07 | 186 | 75 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-06 | 199 | 75 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 158 | 75 | 5 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 158 | 75 | 5 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 75 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 75 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 184 | 75 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.87e-05 | 193 | 75 | 5 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 195 | 75 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.01e-05 | 196 | 75 | 5 | a2db88fad9bbc55685f8e681d120ef38715ca3c4 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.06e-05 | 197 | 75 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.21e-05 | 200 | 75 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.46e-05 | 137 | 75 | 4 | 0bb5cccc31e7c44d44a2db3f59b68f9a81503151 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.70e-05 | 138 | 75 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.71e-05 | 142 | 75 | 4 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.71e-05 | 142 | 75 | 4 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 144 | 75 | 4 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 145 | 75 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 159 | 75 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-04 | 162 | 75 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 162 | 75 | 4 | bc63a96ad3ba0b3433e3679d7a005f47709ff384 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.85e-04 | 168 | 75 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-04 | 169 | 75 | 4 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 172 | 75 | 4 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 172 | 75 | 4 | 53dbfe1ac658fd94370cf8e745048cb67fda1daf | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 178 | 75 | 4 | 5fc9f41609735b972a2cd0830182d13742cd5bf5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.36e-04 | 179 | 75 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.36e-04 | 179 | 75 | 4 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 180 | 75 | 4 | b294f9db1e2ff51c94cde64fae4c2b057c0030a1 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.57e-04 | 183 | 75 | 4 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.68e-04 | 185 | 75 | 4 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.68e-04 | 185 | 75 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.68e-04 | 185 | 75 | 4 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-04 | 186 | 75 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-04 | 186 | 75 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 187 | 75 | 4 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 187 | 75 | 4 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-04 | 187 | 75 | 4 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.85e-04 | 188 | 75 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 189 | 75 | 4 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-04 | 189 | 75 | 4 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-04 | 189 | 75 | 4 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.90e-04 | 189 | 75 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-04 | 189 | 75 | 4 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 2.90e-04 | 189 | 75 | 4 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 190 | 75 | 4 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 2.96e-04 | 190 | 75 | 4 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.96e-04 | 190 | 75 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.96e-04 | 190 | 75 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.02e-04 | 191 | 75 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.08e-04 | 192 | 75 | 4 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 193 | 75 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 193 | 75 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.14e-04 | 193 | 75 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 193 | 75 | 4 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.14e-04 | 193 | 75 | 4 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 193 | 75 | 4 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 193 | 75 | 4 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 194 | 75 | 4 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-04 | 194 | 75 | 4 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.27e-04 | 195 | 75 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.27e-04 | 195 | 75 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.27e-04 | 195 | 75 | 4 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.27e-04 | 195 | 75 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.27e-04 | 195 | 75 | 4 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.33e-04 | 196 | 75 | 4 | aec2b11a6048048820271266fdc8b8d806da9993 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.33e-04 | 196 | 75 | 4 | aa0dc04f94a575cd442ee473b75a4f54268e4105 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.33e-04 | 196 | 75 | 4 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.33e-04 | 196 | 75 | 4 | 502834a16d5ada93af7ab9af0c3dc652086964bd | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.33e-04 | 196 | 75 | 4 | ae9bf04531b9bda819608d90736c4405a6c3df41 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.33e-04 | 196 | 75 | 4 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.33e-04 | 196 | 75 | 4 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | Control-Lymphoid_T/NK-gd_T|Control / Disease group, lineage and cell class | 3.33e-04 | 196 | 75 | 4 | 98b11aada6bc5d928ef618573dc912d4d74a1092 | |
| ToppCell | Healthy/Control-gd_T|World / Disease group and Cell class | 3.33e-04 | 196 | 75 | 4 | b982c84552e7efbff2be861f0f569f40804f5d88 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 3.40e-04 | 197 | 75 | 4 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.40e-04 | 197 | 75 | 4 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-04 | 197 | 75 | 4 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-04 | 197 | 75 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.40e-04 | 197 | 75 | 4 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.40e-04 | 197 | 75 | 4 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.46e-04 | 198 | 75 | 4 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Healthy_donor-gd_T|Healthy_donor / disease group, cell group and cell class (v2) | 3.46e-04 | 198 | 75 | 4 | 25158815287efbdd8f463baa755cbb874f3905f3 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-04 | 198 | 75 | 4 | 5b9a7b9f53a3d9cf8d6e6a7c1c94514b22cf9fa8 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.46e-04 | 198 | 75 | 4 | 323b4e6c31e18227546bb30566c1d872fda45e36 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.46e-04 | 198 | 75 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | distal-2-Hematologic-IGSF21+_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.46e-04 | 198 | 75 | 4 | bcb62e466fc9b9b58cef30a87b98101d19a82ed4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.53e-04 | 199 | 75 | 4 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.53e-04 | 199 | 75 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_CTL|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.53e-04 | 199 | 75 | 4 | a9b7465ecd9fd7c5ad35970ff7c3c93b4ec2c4c3 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-04 | 199 | 75 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.53e-04 | 199 | 75 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.53e-04 | 199 | 75 | 4 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-04 | 199 | 75 | 4 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Efhd2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.58e-04 | 82 | 75 | 3 | 93b75f8822ffe8870195cd1fe0a7286478f61e79 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.60e-04 | 200 | 75 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.60e-04 | 200 | 75 | 4 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.60e-04 | 200 | 75 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.60e-04 | 200 | 75 | 4 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| Drug | cycloferon | 1.13e-10 | 24 | 73 | 6 | CID000038072 | |
| Drug | gunacin | 5.77e-10 | 14 | 73 | 5 | CID000198547 | |
| Drug | pppA2'-5'A2'-5'A | 8.63e-10 | 15 | 73 | 5 | CID000125229 | |
| Drug | podophyllin | 2.44e-09 | 18 | 73 | 5 | CID011979494 | |
| Drug | Nyco | 2.44e-09 | 18 | 73 | 5 | CID000071618 | |
| Drug | Yfrkd | 3.38e-09 | 7 | 73 | 4 | CID000129984 | |
| Drug | ridostin | 3.63e-09 | 116 | 73 | 8 | CID011979623 | |
| Drug | Sesquimustard | 4.89e-09 | 43 | 73 | 6 | CID000019092 | |
| Drug | Chebi:36708 | 6.74e-09 | 8 | 73 | 4 | CID011966289 | |
| Drug | 1hiv | 6.74e-09 | 8 | 73 | 4 | CID005479205 | |
| Drug | formosanin C | 7.44e-09 | 22 | 73 | 5 | CID000073597 | |
| Drug | Hiltonol | 9.48e-09 | 23 | 73 | 5 | CID000431963 | |
| Drug | hycanthone | 1.49e-08 | 25 | 73 | 5 | CID000003634 | |
| Drug | bropirimine | 1.60e-08 | 52 | 73 | 6 | CID000065457 | |
| Drug | ABMP | 1.84e-08 | 26 | 73 | 5 | CID000080567 | |
| Drug | pipobroman | 2.01e-08 | 10 | 73 | 4 | CID000004842 | |
| Drug | inosiplex | 2.25e-08 | 27 | 73 | 5 | CID000037510 | |
| Drug | Lps2 | 3.13e-08 | 58 | 73 | 6 | CID000454710 | |
| Drug | flesinoxan | 3.15e-08 | 11 | 73 | 4 | CID000057347 | |
| Drug | poly rI:rC | 3.95e-08 | 30 | 73 | 5 | CID011979660 | |
| Drug | CHEMBL466993 | 5.55e-08 | 32 | 73 | 5 | CID005320808 | |
| Drug | adefovir | 5.70e-08 | 64 | 73 | 6 | CID000060172 | |
| Drug | R 842 | 6.80e-08 | 13 | 73 | 4 | CID000130714 | |
| Drug | AC1O51IP | 6.88e-08 | 66 | 73 | 6 | CID006450363 | |
| Drug | carprofen | 7.63e-08 | 34 | 73 | 5 | CID000002581 | |
| Drug | tilorone | 8.88e-08 | 35 | 73 | 5 | CID000005475 | |
| Drug | Lanicemine | 9.50e-08 | 14 | 73 | 4 | CID003038485 | |
| Drug | 9-cis-acitretin | 1.07e-07 | 71 | 73 | 6 | CID000041317 | |
| Drug | pyran | 1.19e-07 | 37 | 73 | 5 | CID000033703 | |
| Drug | FMAU | 1.19e-07 | 37 | 73 | 5 | CID000072327 | |
| Drug | anagrelide | 1.36e-07 | 38 | 73 | 5 | CID000002182 | |
| Drug | acyclovir | 1.45e-07 | 124 | 73 | 7 | CID000002022 | |
| Drug | isofagomine lactam | 1.56e-07 | 39 | 73 | 5 | CID000448980 | |
| Drug | YNK01 | 2.24e-07 | 17 | 73 | 4 | CID000084071 | |
| Drug | 1 ind | 2.29e-07 | 42 | 73 | 5 | CID003037877 | |
| Drug | AC1L9FQV | 2.54e-07 | 82 | 73 | 6 | CID000444118 | |
| Drug | p203 | 2.88e-07 | 18 | 73 | 4 | CID000019228 | |
| Drug | AC1L9AL3 | 3.65e-07 | 46 | 73 | 5 | CID000441122 | |
| Drug | entecavir | 4.07e-07 | 47 | 73 | 5 | CID000153941 | |
| Drug | Ciluprevir [USAN] | 4.53e-07 | 20 | 73 | 4 | CID006450803 | |
| Drug | val-mCyd | 4.53e-07 | 20 | 73 | 4 | CID006918726 | |
| Drug | adefovir dipivoxil | 5.04e-07 | 49 | 73 | 5 | CID000060871 | |
| Drug | D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 | 5.04e-07 | 49 | 73 | 5 | CID000365716 | |
| Drug | L DO | 5.58e-07 | 21 | 73 | 4 | CID000097725 | |
| Drug | NMMA | 5.74e-07 | 94 | 73 | 6 | CID000170607 | |
| Drug | trifluorothymidine | 6.17e-07 | 51 | 73 | 5 | CID000006256 | |
| Drug | famciclovir | 6.81e-07 | 52 | 73 | 5 | CID000003324 | |
| Drug | Ampligen | 7.50e-07 | 53 | 73 | 5 | CID000038077 | |
| Drug | imidazoquinoline | 8.78e-07 | 101 | 73 | 6 | CID005351568 | |
| Drug | AC1L1ZCT | 9.84e-07 | 24 | 73 | 4 | CID000038235 | |
| Drug | m IU | 9.92e-07 | 56 | 73 | 5 | CID006852123 | |
| Drug | LB80380 | 1.17e-06 | 25 | 73 | 4 | CID006480442 | |
| Drug | Azitidin | 1.18e-06 | 169 | 73 | 7 | CID000005726 | |
| Drug | rosuvastatin | 1.29e-06 | 59 | 73 | 5 | CID000446157 | |
| Drug | AC1L1U53 | 1.40e-06 | 60 | 73 | 5 | CID000060907 | |
| Drug | bromcresol green | 1.45e-06 | 110 | 73 | 6 | CID000006451 | |
| Drug | VX-497 | 1.61e-06 | 27 | 73 | 4 | CID000153241 | |
| Drug | AC1NRD2B | 1.88e-06 | 28 | 73 | 4 | CID005289317 | |
| Drug | resiquimod | 1.88e-06 | 115 | 73 | 6 | CID000159603 | |
| Drug | AC1L1HZP | 1.94e-06 | 64 | 73 | 5 | CID000004361 | |
| Drug | NM 108 | 2.17e-06 | 29 | 73 | 4 | CID000500901 | |
| Drug | copolymer 1 | 2.26e-06 | 66 | 73 | 5 | CID003081884 | |
| Drug | penciclovir | 2.50e-06 | 30 | 73 | 4 | CID000004725 | |
| Drug | DZNep | 2.50e-06 | 30 | 73 | 4 | CID000073087 | |
| Drug | vindesine | 2.63e-06 | 68 | 73 | 5 | CID000040839 | |
| Drug | U-10149A | 2.78e-06 | 123 | 73 | 6 | CID000003928 | |
| Drug | cycloleucine | 2.82e-06 | 69 | 73 | 5 | CID000002901 | |
| Drug | N6-methyl-(R)-roscovitine | 3.26e-06 | 71 | 73 | 5 | CID005289296 | |
| Drug | EDSS | 3.67e-06 | 129 | 73 | 6 | CID000123395 | |
| Drug | 2',3'-dideoxycytidine diphosphate | 4.00e-06 | 74 | 73 | 5 | CID000128494 | |
| Drug | imiquimod | 4.19e-06 | 132 | 73 | 6 | CID000057469 | |
| Drug | neopterine | 4.38e-06 | 133 | 73 | 6 | CID000004455 | |
| Drug | 1 Jak | 4.56e-06 | 76 | 73 | 5 | CID000446429 | |
| Drug | 2',3'-dideoxycytidine (ddC | 4.56e-06 | 76 | 73 | 5 | CID000005718 | |
| Drug | lobucavir | 4.72e-06 | 35 | 73 | 4 | CID000060786 | |
| Drug | AC1MMF4B | 4.87e-06 | 77 | 73 | 5 | CID003260010 | |
| Drug | mu-I | 5.19e-06 | 78 | 73 | 5 | CID011987863 | |
| Drug | MCNU | 5.30e-06 | 36 | 73 | 4 | CID000071741 | |
| Drug | A809128 | 5.30e-06 | 36 | 73 | 4 | CID003392279 | |
| Drug | Zinetac | 5.88e-06 | 80 | 73 | 5 | CID000005039 | |
| Drug | DNTB | 6.01e-06 | 216 | 73 | 7 | CID000015325 | |
| Drug | rifampicin | 6.12e-06 | 306 | 73 | 8 | CID005381226 | |
| Drug | DTIC | 6.25e-06 | 81 | 73 | 5 | CID005281007 | |
| Drug | fotemustine | 6.61e-06 | 38 | 73 | 4 | CID000104799 | |
| Drug | glycrrhizin | 8.39e-06 | 86 | 73 | 5 | CID000003495 | |
| Drug | AC1O52EF | 8.84e-06 | 13 | 73 | 3 | CID006450817 | |
| Drug | 2'-deoxy-3'-thiacytidine | 8.88e-06 | 87 | 73 | 5 | CID000003877 | |
| Drug | C12063 | 9.20e-06 | 429 | 73 | 9 | CID005282055 | |
| Drug | diethyl acetylenedicarboxylate | 1.01e-05 | 2 | 73 | 2 | CID000069803 | |
| Drug | Murabutida | 1.09e-05 | 43 | 73 | 4 | CID005362018 | |
| Drug | NSC 312887 | 1.09e-05 | 43 | 73 | 4 | CID000003368 | |
| Drug | oligoadenylate | 1.14e-05 | 157 | 73 | 6 | CID000107918 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.36e-05 | 162 | 73 | 6 | CID000072363 | |
| Drug | dipyridamole | 1.36e-05 | 162 | 73 | 6 | CID000003108 | |
| Drug | amantadine | 1.37e-05 | 95 | 73 | 5 | CID000002130 | |
| Drug | busulfan | 1.51e-05 | 97 | 73 | 5 | CID000002478 | |
| Drug | poly(I-C | 1.85e-05 | 171 | 73 | 6 | CID000213546 | |
| Drug | 5H-purin-2-amine | 1.93e-05 | 102 | 73 | 5 | CID000409844 | |
| Drug | Leucine enkephalin | 2.66e-05 | 109 | 73 | 5 | CID000003903 | |
| Drug | NSC105014 | 2.78e-05 | 110 | 73 | 5 | CID000001546 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.03e-04 | 9 | 71 | 2 | C3502809 | |
| Disease | Squamous cell carcinoma | 2.32e-04 | 124 | 71 | 4 | C0007137 | |
| Disease | Colorectal Carcinoma | 2.80e-04 | 702 | 71 | 8 | C0009402 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 3.59e-04 | 139 | 71 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Hermansky-Pudlak syndrome (implicated_via_orthology) | 5.10e-04 | 14 | 71 | 2 | DOID:3753 (implicated_via_orthology) | |
| Disease | P wave duration | 5.87e-04 | 15 | 71 | 2 | EFO_0005094 | |
| Disease | Hypertriglyceridemia | 5.87e-04 | 15 | 71 | 2 | C0020557 | |
| Disease | triglycerides in very small VLDL measurement | 5.98e-04 | 68 | 71 | 3 | EFO_0022144 | |
| Disease | Schizoaffective disorder-bipolar type | 6.70e-04 | 16 | 71 | 2 | EFO_0009965 | |
| Disease | muscular dystrophy (is_implicated_in) | 7.58e-04 | 17 | 71 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | non-small cell lung carcinoma | 7.96e-04 | 75 | 71 | 3 | EFO_0003060 | |
| Disease | Anorexia | 8.52e-04 | 18 | 71 | 2 | C0003123 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.05e-03 | 20 | 71 | 2 | DOID:3328 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 1.05e-03 | 20 | 71 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Neutropenia | 1.16e-03 | 21 | 71 | 2 | C0027947 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 1.52e-03 | 24 | 71 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | response to antiviral drug, cirrhosis of liver | 1.52e-03 | 24 | 71 | 2 | EFO_0001422, EFO_0010123 | |
| Disease | Fever | 1.93e-03 | 27 | 71 | 2 | C0015967 | |
| Disease | platelet crit | 2.01e-03 | 952 | 71 | 8 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNNQATNVIKFSDPQ | 161 | O94986 | |
| KFQNPQTEGVNAVED | 201 | Q2M2I8 | |
| EPVQNGELFFQKFQT | 5056 | Q8WXG9 | |
| QQSEEAFPQEQQKAP | 71 | O94923 | |
| KEGVFPDNFAVQINE | 316 | Q9Y5K6 | |
| QGNVFSNKQDPLERQ | 211 | O75618 | |
| DFIDENGLPINKNEN | 1686 | Q12830 | |
| EFINDNNNQFKKFPQ | 181 | Q9Y2K5 | |
| QFSSNKEQNGVQDPQ | 31 | Q9NRA1 | |
| FSQEFQRDKQPNAQP | 871 | Q7L576 | |
| IPQEEFDGNQFQKAQ | 61 | P01566 | |
| EINNKLEFESAQFPN | 221 | P01584 | |
| FPQEEFDGNQFQKAQ | 61 | P01570 | |
| QSVFEEPNNENKNAL | 371 | H3BQL2 | |
| QQFLPQFPEDSAEQQ | 71 | Q6P4R8 | |
| FEKPSIEQGVNNFVQ | 216 | Q92831 | |
| IQEQFQKNPDSYNGA | 171 | Q8IVD9 | |
| KPNSQGQAQTFLQEE | 621 | Q96H55 | |
| FPQEEFDGNQFQKAQ | 61 | P01568 | |
| EIKAIFPNGQFQGDN | 156 | Q13191 | |
| FPQEEFDGNQFQKAP | 61 | P01562 | |
| FPQEEFDGNQFQKAQ | 61 | P01569 | |
| FEAIVEPVNGKFNDN | 326 | Q9Y4C0 | |
| PLNIKQNNKQAFDGF | 1091 | Q8N3D4 | |
| HANIIFPNKQEQEFN | 511 | Q07864 | |
| NSPQLSAQENFQFDK | 391 | Q6P9B6 | |
| SPKTFEEVQFFNGNN | 626 | Q9H3R1 | |
| NVLQEFFQNPDFKLG | 311 | A4FU69 | |
| FDFQANAQLSNPKIN | 2806 | P04114 | |
| QKDLNTGVFNNQENE | 606 | O60741 | |
| QSVFEEPNNENKNAL | 371 | D6RF30 | |
| TQKNRQFFNEPEENF | 86 | P86791 | |
| KQFVPQFISQLQNEF | 71 | P12110 | |
| TQKNRQFFNEPEENF | 86 | P86790 | |
| IQDNKFIEAGQFNDN | 686 | Q92796 | |
| NPNVGFQRQLQEFEK | 126 | Q9NRW4 | |
| LEDVPFSQNAGQKNQ | 596 | Q9Y6X4 | |
| DFQLFTGNKIQDEEN | 326 | Q96HE7 | |
| QSVFEEPNNENKNAL | 371 | P0CJ92 | |
| FPQEEFGNQFQKAET | 61 | P01563 | |
| KVQDINDNAPEFLNG | 156 | P55286 | |
| EKVFQGNSNFRDPVQ | 366 | Q8N8Z6 | |
| KDQKQPTQNGQEELF | 176 | Q8NG08 | |
| LPQEEFDGNQFQKTQ | 61 | P01571 | |
| GQTNEIFKAVDENNN | 2056 | P56715 | |
| FPQEEFDGNQFQKAE | 61 | P05013 | |
| AQAAAQAPENFQEGK | 71 | Q5H9L4 | |
| PANDFANVTEKQQFA | 431 | A2RUB1 | |
| FQDQPAQLNLGNNFK | 196 | Q8N4H0 | |
| DPEQIFQNIQFQKDL | 46 | Q7Z5M5 | |
| NKNLFSQAFPENGDN | 6436 | Q8NF91 | |
| FPQEVFDGNQFQKAQ | 61 | P05015 | |
| QKQALQEEFFHNPQA | 171 | P28715 | |
| QALEPKQDAFQGQEA | 1086 | Q9Y6Q9 | |
| DGIQVNSQFQQEFPS | 131 | Q9Y520 | |
| NPADLEFQQDFGNIV | 221 | Q8NEZ3 | |
| DQVAFNGLPQFVQDL | 401 | P14410 | |
| PEQPFEKAAFQKQND | 761 | P46087 | |
| AQQRPYENFQNTEGK | 421 | Q13546 | |
| LQDQKNFDPVQIEQE | 536 | Q6Q759 | |
| QFSVKNNTDQFPQLQ | 556 | Q86WS4 | |
| FGDQAKQRENQKFPT | 396 | Q70EK8 | |
| QEDGPDQQQNLTEQF | 461 | O94967 | |
| FQQDKSDQRENSPVQ | 1046 | Q7Z2Z1 | |
| QKAPRFKDFQQQDSQ | 281 | Q70EL2 | |
| DAQSFQQEVIPKGQQ | 1016 | Q9Y5Y9 | |
| TENKNVEFPNQNFSE | 566 | Q9BX26 | |
| ATQAANQGEFQKPDN | 111 | Q9UKY0 | |
| PAEQQDFLFNQDNKD | 1791 | Q8WWQ8 | |
| NQFPQELNVGKVSAE | 991 | O14795 | |
| EFEGLFKQPAENVNQ | 651 | P22314 | |
| KNLTFFINDEQQGPI | 656 | Q9C026 | |
| SDIQEDNKIPFNQND | 431 | Q86YA3 | |
| IQFPDKDDGNQPQDQ | 1086 | Q00341 | |
| NQKNQEGFTVFQIRP | 486 | Q2M3C6 | |
| PQENFEQNKFGENSR | 151 | Q8TF47 | |
| LNVKQAFNPEGEFQR | 471 | Q9UBF9 |